Comparison of body habitus in patients with pulmonary arterial hypertension enrolled in the registry to evaluate early and long-term PAH disease management with normative values from the national health and nutrition examination survey
Open accessAbstract
Objective To investigate the correlation between body mass index (BMI) and pulmonary artery systolic pressure in a large population of patients with pulmonary arterial hypertension (PAH).Patients and methods The BMI of patients with group 1 PAH enrolled in the Registry to Evaluate Early and Long-term PAH Disease Management (REVEAL) was compared with that of age- and sex-matched controls in the National Health and Nutrition Examination Survey (NHANES) to clarify whether obesity is linked with PAH. The diagnosis of PAH was defined in REVEAL by right-sided heart catheterization. Differences in BMI and the percentage of patients considered obese (BMI ≥30) and underweight (BMI <18.5) in various subgroups of patients enrolled in REVEAL from March 30, 2006, through September 11, 2007, were determined.Results Mean BMI was no different for patients with PAH (n=2141) than for the NHANES normal comparison group; however, the proportion of obese and underweight patients was increased in patients with PAH. Subgroup analysis demonstrated that subgroups with idiopathic PAH and those with PAH associated with drugs and toxins had both higher BMI and percentage of obese patients, whereas 3 other subgroups (those with PAH associated with congenital heart disease, connective tissue disease, and human immunodeficiency virus) had lower mean BMI.Conclusion Mean BMI of the REVEAL patients was the same as that of the NHANES normal comparison group; however, there were higher percentages of obese and underweight patients in REVEAL. This discrepancy can be explained by the balancing effect of more overweight and underweight patients in different PAH subgroups. The reason for the increased frequency of obesity in idiopathic PAH is unknown, and additional study is needed.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Obesity, hyperlipidemia, and systemic hypertension are common risk factors for Group I PAH as well as Group II PH and are also a feature of HIV infection.
“For example, obesity, hyperlipidemia, and systemic hypertension are common risk factors for Group I PAH as well as Group II (secondary to left-sided heart failure or PH-heart failure with preserved ejection fraction, HFpEF)[12,15,16], and are also a feature of HIV infection[17,18].”
From Enterosalivary nitrate metabolism and the microbiome: Intersection of microbial metabolism, nitric oxide and diet in cardiac and pulmonary vascular health (2017) · cites this paper as [16]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
(2000) · PubMed · Cited by 13,173 · see citing works
Obesity : Preventing and managing the global epidemic
Akram, D. S., Astrup, A. V., Atinmo, T., Boissin, J.-L., Bray, G. A., Carroll, K. N., Chitson, P., Chen, C., Dietz, W. H., Hill, J. O., et al. (2000) · Research at the University of Copenhagen (University of Copenhagen) · Cited by 12,945 · see citing works
Updated clinical classification of pulmonary hypertension
Simonneau, G., Gatzoulis, M. A., Adatia, I., Celermajer, D., Denton, C., Ghofrani, A., Gomez Sanchez, M. A., Krishna Kumar, R., Landzberg, M., Machado, R. F., et al. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.10.029 · Cited by 4,191 · see citing works
ACCF/AHA 2009 Expert Consensus Document on Pulmonary Hypertension
McLaughlin, V. V., Archer, S. L., Badesch, D. B., Barst, R. J., Farber, H. W., Lindner, J. R., Mathier, M. A., McGoon, M. D., Park, M., Rosenson, R. S., et al. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.01.004 · Cited by 2,354 · see citing works
Self-citationUpdated Clinical Classification of Pulmonary Hypertension
Simonneau, G., Robbins, I. M., Beghetti, M., Channick, R. N., Delcroix, M., Denton, C. P., Elliott, C. G., Gaine, S., Gladwin, M. T., Jing, Z., et al. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.04.012 · Cited by 2,090 · see citing works
Ogden, C. L., Yanovski, S. Z., Carroll, M. D., & Flegal, K. M. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.03.052 · Cited by 1,561 · see citing works
Pulmonary Arterial Hypertension
Badesch, D. B., Raskob, G. E., Elliott, C. G., Krichman, A. M., Farber, H. W., Frost, A., Barst, R. J., Benza, R. L., Liou, T. G., Turner, M. P., et al. (2009) · CHEST Journal · doi:10.1378/chest.09-1140 · Cited by 1,179 · see citing works
Self-citationAppetite-suppressant drugs and the risk of primary pulmonary hypertension
Abenhaim, L., Moride, Y., Brenot, F., Rich, S., Benichou, J., Kurz, X., Higenbottam, T., Oakley, C., Wouters, E., Aubier, M., et al. (1996) · New England Journal of Medicine · doi:10.1056/nejm199608293350901 · Cited by 1,162 · see citing works
ACCF/AHA 2009 Expert Consensus Document on Pulmonary Hypertension
McLaughlin, V. V., Archer, S. L., Badesch, D. B., Barst, R. J., Farber, H. W., Lindner, J. R., Mathier, M. A., McGoon, M. D., Park, M., Rosenson, R. S., et al. (2009) · Circulation · doi:10.1161/circulationaha.109.192230 · Cited by 1,085 · see citing works
Self-citationMcQuillan, B., Picard, M. H., Leavitt, M. B., & Weyman, A. E. (2001) · Circulation · doi:10.1161/hc4801.100076 · Cited by 669 · see citing works
Appetite-suppressant drugs and the risk of primary pulmonary hypertension
Abenhaim, L. (1997) · ACC Current Journal Review · doi:10.1016/s1062-1458(97)89579-7 · Cited by 562 · see citing works
Lung Function Impairment and Metabolic Syndrome
Leone, N., Courbon, D., Thomas, F., Bean, K., Jégo, B., Leynaert, B., Guize, L., & Zureik, M. (2009) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200807-1195oc · Cited by 531 · see citing works
The Changing Picture of Patients With Pulmonary Arterial Hypertension in the United States
Frost, A., Badesch, D. B., Barst, R. J., Benza, R. L., Elliott, C. G., Farber, H. W., Krichman, A. M., Liou, T. G., Raskob, G. E., Wason, P., et al. (2010) · CHEST Journal · doi:10.1378/chest.10-0075 · Cited by 355 · see citing works
Self-citationPulmonary arterial hypertension in patients with sleep apnoea syndrome
Bady, E. (2000) · Thorax · doi:10.1136/thorax.55.11.934 · Cited by 225 · see citing works
Obesity Is a Common Comorbidity in Children With Congenital and Acquired Heart Disease
Pinto, N. M., Marino, B. S., Wernovsky, G., de Ferranti, S. D., Walsh, A. Z., LaRonde, M., Hyland, K. A., Dunn, S. O., & Cohen, M. S. (2007) · PEDIATRICS · doi:10.1542/peds.2007-0306 · Cited by 211 · see citing works
Kessler, R., Chaouat, A., Weitzenblum, E., Oswald, M., Ehrhart, M., Apprill, M., & Krieger, J. (1996) · European Respiratory Journal · doi:10.1183/09031936.96.09040787 · Cited by 204 · see citing works
Anorexigens and Pulmonary Hypertension in the United States
Rich, S., Rubin, L. J., Walker, A. M., Schneeweiß, S., & Abenhaim, L. (2000) · CHEST Journal · doi:10.1378/chest.117.3.870 · Cited by 190 · see citing works
Prevalence of cardiovascular risk factors in adults with congenital heart disease
Moons, P., Deyk, K. V., Dedroog, D., Troost, E., & Budts, W. (2006) · European Journal of Cardiovascular Prevention & Rehabilitation · doi:10.1097/01.hjr.0000197472.81694.2b · Cited by 184 · see citing works
Design of the REVEAL Registry for US Patients With Pulmonary Arterial Hypertension
McGoon, M. D., Krichman, A. M., Farber, H. W., Barst, R. J., Raskob, G. E., Liou, T. G., Miller, D. P., Feldkircher, K., & Giles, S. (2008) · Mayo Clinic Proceedings · doi:10.4065/83.8.923 · Cited by 149 · see citing works
Self-citationBolland, M. J., Grey, A. B., Gamble, G. D., & Reid, I. R. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-1660 · Cited by 126 · see citing works
Physical activity levels in adults with congenital heart disease
Dua, J., Cooper, A. R., Fox, K. R., & Stuart, G. (2007) · European Journal of Cardiovascular Prevention & Rehabilitation · doi:10.1097/hjr.0b013e32808621b9 · Cited by 111 · see citing works
Epidemiology of Pulmonary Arterial Hypertension
Taichman, D. B., & Mandel, J. (2013) · Clinics in Chest Medicine · doi:10.1016/j.ccm.2013.08.010 · Cited by 88 · see citing works
ESPEN Guidelines on Enteral Nutrition: Wasting in HIV and other chronic infectious diseases
Ockenga, J., Grimble, R. F., Jonkers‐Schuitema, C. F., Macallan, D. C., Melchior, J., Sauerwein, H. P., Schwenk, A., & Süttmann, U. (2006) · Clinical Nutrition · doi:10.1016/j.clnu.2006.01.016 · Cited by 68 · see citing works
Severe pulmonary hypertension in postmenopausal obese women.
Taraseviciute, A., & Voelkel, N. F. (2006) · PubMed · Cited by 67 · see citing works
Catenacci, V. A., Hill, J. O., & Wyatt, H. (2009) · Clinics in Chest Medicine · doi:10.1016/j.ccm.2009.05.001 · Cited by 54 · see citing works
Anorectic Drugs and Pulmonary Hypertension from the Bedside to the Bench
Michelakis, E. D., & Weir, Ε. K. (2001) · The American Journal of the Medical Sciences · doi:10.1097/00000441-200104000-00009 · Cited by 53 · see citing works
Epidemiology of Pulmonary Arterial Hypertension
Taichman, D. B., & Mandel, J. (2007) · Clinics in Chest Medicine · doi:10.1016/j.ccm.2006.11.012 · Cited by 39 · see citing works
Pulmonary Arterial Hypertension and Obesity†
Williams, W. H., Safford, R. E., Heckman, M. G., Crook, J. E., & Burger, C. D. (2010) · The Open Obesity Journal · doi:10.2174/1876823701002010132 · Cited by 7 · see citing works
Self-citation
Flagged first, then by citations
Research works printed but not linked: 1
- Badesch DB, Raskob GE, Elliott CG, et al. Pulmonary arterial hyperten- sion: baseline characteristics from the REVEAL registry. Chest. 2010;137:376- 387.
Cited by
Sorted by citations
REVEAL: a contemporary US pulmonary arterial hypertension registry
McGoon, M. D., & Miller, D. P. (2012) · European Respiratory Review · doi:10.1183/09059180.00008211 · Cited by 272 · see citing works
Self-citationKoch, C. D., Gladwin, M. T., Freeman, B. A., Lundberg, J. O., Weitzberg, E., & Morris, A. (2017) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2016.12.015 · Cited by 186 · see citing works
Comorbid Conditions and Outcomes in Patients With Pulmonary Arterial Hypertension
Poms, A. D., Turner, M. P., Farber, H. W., Meltzer, L. A., & McGoon, M. D. (2013) · CHEST Journal · doi:10.1378/chest.11-3241 · Cited by 164 · see citing works
Self-citationKholdani, C., Fares, W. H., & Mohsenin, V. (2015) · Pulmonary Circulation · doi:10.1086/679995 · Cited by 127 · see citing works
Talati, M. H., & Hemnes, A. R. (2015) · Pulmonary Circulation · doi:10.1086/681227 · Cited by 109 · see citing works
Kelley, E. E., Baust, J., Bonacci, G., Golin-Bisello, F., Devlin, J. E., St. Croix, C. M., Watkins, S. C., Gor, S., Cantu-Medellin, N., Weidert, E. R., et al. (2014) · Cardiovascular Research · doi:10.1093/cvr/cvt341 · Cited by 95 · see citing works
Haemodynamic effects of non‐invasive ventilation in patients with obesity‐hypoventilation syndrome
Castro‐Añón, O., Golpe, R., Pérez‐de‐Llano, L. A., González, M. J. L., VELASQUEZ, E. J. E., FERNÁNDEZ, R. P., Testa-Fernández, A. M., & González‐Quintela, A. (2012) · Respirology · doi:10.1111/j.1440-1843.2012.02252.x · Cited by 80 · see citing works
Zafrir, B., Adir, Y., Shehadeh, W., Shteinberg, M., Salman, N., & Amir, O. (2012) · Respiratory Medicine · doi:10.1016/j.rmed.2012.10.019 · Cited by 74 · see citing works
The hallmarks of severe pulmonary arterial hypertension: the cancer hypothesis—ten years later
Cool, C. D., Kuebler, W. M., Bogaard, H. J., Spiekerkoetter, E. F., Nicolls, M. R., & Voelkel, N. F. (2020) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00476.2019 · Cited by 64 · see citing works
Summer, R. S., Walsh, K. X., & Medoff, B. D. (2011) · Pulmonary Circulation · doi:10.4103/2045-8932.93542 · Cited by 52 · see citing works
Obesity and airway responsiveness: Role of TNFR2
Williams, A. S., Chen, L., Kasahara, D. I., Si, H., Wurmbrand, A. P., & Shore, S. A. (2012) · Pulmonary Pharmacology & Therapeutics · doi:10.1016/j.pupt.2012.05.001 · Cited by 51 · see citing works
Heresi, G. A., Malin, S. K., Barnes, J. W., Tian, L., Kirwan, J. P., & Dweik, R. A. (2017) · Annals of the American Thoracic Society · doi:10.1513/annalsats.201608-605oc · Cited by 46 · see citing works
Mazimba, S., Holland, E., Nagarajan, V., Mihalek, A. D., Kennedy, J. L. W., & Bilchick, K. C. (2017) · International Journal of Obesity · doi:10.1038/ijo.2017.45 · Cited by 38 · see citing works
McCully, B. H., Hasan, W., Streiff, C. T., Houle, J. C., Woodward, W. R., Giraud, G. D., Brooks, V. L., & Habecker, B. A. (2013) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00196.2013 · Cited by 37 · see citing works
Prevalence of metabolic syndrome in patients with pulmonary hypertension
Ussavarungsi, K., Thomas, C. S., & Burger, C. D. (2015) · The Clinical Respiratory Journal · doi:10.1111/crj.12406 · Cited by 35 · see citing works
Self-citationLuo, L., Zheng, W., Lian, G., Chen, H., Li, L., Xu, C., & Xie, L. (2017) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2017.3226 · Cited by 34 · see citing works
Jonas, K., Waligóra, M., Magoń, W., Zdrojewski, T. R., Stokwiszewski, J., Płazak, W., Podolec, P. S., & Kopeć, G. (2018) · Archives of Medical Science · doi:10.5114/aoms.2018.79242 · Cited by 29 · see citing works
Nitrated fatty acids in cardiovascular diseases
Mollenhauer, M., Mehrkens, D., & Rudolph, V. (2018) · Nitric Oxide · doi:10.1016/j.niox.2018.03.016 · Cited by 29 · see citing works
Reddy, Y. N. V., Frantz, R. P., Hassoun, P. M., Hemnes, A. R., Horn, E. M., Leopold, J. A., Rischard, F. P., Rosenzweig, E. B., Hill, N. S., ERZURUM, S. C., et al. (2024) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2024.08.061 · Cited by 28 · see citing works
DuBrock, H. M., Burger, C. D., Bartolome, S., Feldman, J. P., Ivy, D. D., Rosenzweig, E. B., Sager, J. S., Presberg, K. W., Mathai, S. C., Lammi, M. R., et al. (2021) · Pulmonary Circulation · doi:10.1177/20458940211020913 · Cited by 26 · see citing works
Self-citationCalorie Restriction Attenuates Monocrotaline-induced Pulmonary Arterial Hypertension in Rats
Ding, M., Lei, J., Qu, Y., Zhang, H., Xin, W., Ma, F., Liu, S., Li, Z., Jin, F., & Fu, E. (2015) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0000000000000224 · Cited by 24 · see citing works
Thayer, T. E., Levinson, R. T., Huang, S., Assad, T. R., Farber‐Eger, E. H., Wells, Q. S., Mosley, J. D., & Brittain, E. L. (2020) · CHEST Journal · doi:10.1016/j.chest.2020.07.038 · Cited by 22 · see citing works
Hu, E., He, J., Liu, Z., Ni, X., Zheng, Y., Gu, Q., Zhao, Z., & Xiong, C. (2014) · Acta cardiologica. Supplementum · doi:10.1080/ac.69.6.1000010 · Cited by 20 · see citing works
The Use of Antidepressants and the Risk of Idiopathic Pulmonary Arterial Hypertension
Fox, B. D., Azoulay, L., Dell’Aniello, S., Langleben, D., Lapi, F., Benisty, J. I., & Suissa, S. (2014) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2014.09.031 · Cited by 18 · see citing works
Pulmonary hypertension and insulin resistance: a mechanistic overview
Zanotto, T. M., Gonçalves, A. E. D. S. S., & Saad, M. J. A. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1283233 · Cited by 17 · see citing works
Fat, fire and muscle – The role of adiponectin in pulmonary vascular inflammation and remodeling
Medoff, B. D. (2012) · Pulmonary Pharmacology & Therapeutics · doi:10.1016/j.pupt.2012.06.006 · Cited by 16 · see citing works
Held, M., Mittnacht, M., Kolb, M. R. J., Karl, S., & Jany, B. (2014) · PLoS ONE · doi:10.1371/journal.pone.0107480 · Cited by 14 · see citing works
Pulmonary Circulation in Obesity, Diabetes, and Metabolic Syndrome
Khaing, P., Pandit, P., Awsare, B. K., & Summer, R. S. (2019) · Comprehensive physiology · doi:10.1002/cphy.c190018 · Cited by 15 · see citing works
Carasso, S., Williams, L. K., Hazanov, Y., Halhla, Y., Ghanim, D., & Amir, O. (2016) · International Journal of Cardiology · doi:10.1016/j.ijcard.2016.09.023 · Cited by 7 · see citing works
Polychlorinated Biphenyls and Pulmonary Hypertension
Assaggaf, H. M., Yoo, C., Lucchini, R. G., Black, S. M., Hamed, M., Minshawi, F., & Felty, Q. H. (2022) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph19084705 · Cited by 7 · see citing works
Pulmonary Circulation in Obesity, Diabetes, and Metabolic Syndrome
Khaing, P., Pandit, P., Awsare, B. K., & Summer, R. S. (2020) · Comprehensive physiology · doi:10.1002/j.2040-4603.2020.tb00111.x · Cited by 5 · see citing works
Shujaat, A., Bellardini, J., Girdhar, A., & Bajwa, A. A. (2014) · Pulmonary Circulation · doi:10.1086/675987 · Cited by 5 · see citing works
Obesity and pulmonary hypertension
Antkowiak, M., & Channick, R. N. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-813553-2.00009-9 · Cited by 4 · see citing works
Assessment of noggin level in pulmonary arterial hypertension patients
Al-Khafaji, K. H. A., Al-Dujaili, M. N., & Al-Dujaili, A. N. (2018) · Current Issues in Pharmacy and Medical Sciences · doi:10.1515/cipms-2018-0024 · Cited by 2 · see citing works
Altered metabolism in pulmonary hypertension: fuelling the fire or just smoke?
Duan, D., Gu, C., & Jun, J. C. (2020) · European Respiratory Journal · doi:10.1183/13993003.00447-2020 · Cited by 2 · see citing works
Obesity, Metabolic Syndrome, and Pulmonary Hypertension
Badlam, J. B. (2024) · Respiratory medicine · doi:10.1007/978-3-031-52696-1_13 · Cited by 1 · see citing works
Pathogenesis of Pulmonary Arterial Hypertension
Trammell, A. W., & Hemnes, A. R. (2015) · Respiratory medicine · doi:10.1007/978-1-4939-2636-7_3 · Cited by 1 · see citing works
Zanella, P. B., Ávila, C. C., & de Souza, C. G. (2018) · Journal of the American College of Nutrition · doi:10.1080/07315724.2017.1417925 · Cited by 1 · see citing works
Vaidy, A., Forfia, P. R., Mazurek, J. A., & Vaidya, A. (2021) · BMJ Case Reports · doi:10.1136/bcr-2018-228358 · Cited by 1 · see citing works
Pu, S., Yin, L., Wen, B., & He, J. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2021.680223 · Cited by 1 · see citing works
Heritable and Idiopathic Forms of Pulmonary Arterial Hypertension
Austin, E. D., Newman, J. H., Loyd, J. E., & Phillips, J. A. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-812532-8.00016-1 · Cited by 1 · see citing works
Evaluation of Pulmonary Risks Associated with Selected Occupations
Harbison, S. C. (2013) · Digital Commons - University of South Florida (University of South Florida) · Cited by 1 · see citing works
Obesity, the Metabolic Syndrome, and Pulmonary Hypertension
Hemnes, A. R., & Robbins, I. M. (2012) · Humana Press eBooks · doi:10.1007/978-1-62703-053-3_9
Respiratory Diseases in Obesity
Chapman, D. G., Suratt, B. T., & Dixon, A. E. (2014) · Humana Press eBooks · doi:10.1007/978-1-62703-770-9_19
Heritable and Idiopathic Forms of Pulmonary Arterial Hypertension
Austin, E. D., Newman, J. H., Loyd, J. E., & Phillips, J. A. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-383834-6.00054-9
The Future of Pulmonary Hypertension
Frantz, R. P. (2015) · Springer eBooks · doi:10.1007/978-3-319-23594-3_23
Molecular Risk Factors of Pulmonary Arterial Hypertension
Assaggaf, H. M. (2017) · doi:10.25148/etd.fidc004013
Al-Khafaji, K. H. A., Al-Dujaili, M. N., & Al-Dujaili, A. N. (2018) · Current Issues in Pharmacy and Medical Sciences · doi:10.1515/cipms-2018-0032
Studer, S. M., & Coplan, B. (2013) · Advances in Pulmonary Hypertension · doi:10.21693/1933-088x-12.2.96
What is a Nutritional Lifestyle?
Mueller, D. H. (2012) · Advances in Pulmonary Hypertension · doi:10.21693/1933-088x-10.4.219
Impact of body mass index on the risk assessment of mortality in pulmonary arterial hypertension
Ismail, M., Soliman, Y. M. A., & Elkorashy, R. I. (2020) · Egyptian Journal of Chest Diseases and Tuberculosis · doi:10.4103/ejcdt.ejcdt_59_19
Diagnosis and prognosis in connective tissue disease associated pulmonary hypertension
Benjamin, ., & Schreiber, E. (2013)
Hughes, A. L., & Hemnes, A. R. (2021) · Current Opinion in Pulmonary Medicine · doi:10.1097/mcp.0000000000000794
Correlation of body mass index and pulmonary hypertension in patients with obstructive sleep apnoea
Mishra, S. K., Srivastava, G. N., Mishra, J. K., & Oli, R. (2021) · The Journal of Community Health Management · doi:10.18231/j.jchm.2021.018
Obesity and its Influence on the Development of Pulmonary HypertensionPreprint
Karna, R., Asawa, P., Din, M. T. U., Nasrullah, A., Raina, A., & Kassis‐George, H. (2022) · SSRN Electronic Journal · doi:10.2139/ssrn.4067187
Chronic Pulmonary Disease and Lifestyle Medicine
Eschbach, E., Saini, S., & Chun, G. B. (2025) · Springer eBooks · doi:10.1007/978-3-031-82888-1_11
- Authors
- Burger, C. D., Foreman, A. J., Miller, D. P., Safford, R. E., McGoon, M. D., & Badesch, D. B.
- Affiliations
- Mayo Clinic (US)
- University of Colorado Health (US)
- Corresponding author
- Burger, Charles D.
- Venue
- Mayo Clinic Proceedings
- Publisher
- Elsevier BV
- Published
- 2011-02
- Volume
- 86
- Issue
- 2
- Pages
- 105-112
- ISSN
- 0025-6196 (ISSN-L)
- PMC
- PMC3031434
- OpenAlex
- W1994408786
- Cited by
- 56
- References
- 27
- Citations by year
- 2025: 1 · 2024: 3 · 2022: 3 · 2021: 4 · 2020: 5 · 2019: 2 · 2018: 6 · 2017: 4 · 2016: 2 · 2015: 6 · 2014: 6 · 2013: 6 · 2012: 7
- FWCI
- 5.44
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Mayo Clinic Proceedings (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Actelion Pharmaceuticals
- Topics
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Pulmonary Hypertension Research and Treatments
- Health Sciences › Medicine › Genetics › Vascular Anomalies and Treatments
- Health Sciences › Medicine › Internal Medicine › Venous Thromboembolism Diagnosis and Management
- Keywords
- pulmonary arterial hypertension, body mass index, obesity, underweight, pulmonary artery systolic pressure, idiopathic pulmonary arterial hypertension, drug-induced pulmonary arterial hypertension, connective tissue diseases, congenital heart disease, HIV-associated pulmonary arterial hypertension, REVEAL registry
- MeSH terms
- Adolescent, Adult, Aged, Blood Pressure, Child, Child, Preschool, Female, Humans, Hypertension, Pulmonary, Male, Middle Aged, Obesity, Thinness, United States, Body Mass Index, Case-Control Studies
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
